Related Experiment Video
Updated: Jun 15, 2025

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair
Huangqi Tang1,2, Ya-Fei Lu1, Rongsheng Zeng1
1Shenzhen University International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen 518055, China.
Abstract:
Breast Cancer Type 1 Susceptibility Protein (BRCA1) is a tumor-suppressor protein that regulates various cellular pathways, including those that are essential for preserving genome stability. One essential mechanism involves a BRCA1-A complex that is recruited to double-strand breaks (DSBs) by RAP80 before initiating DNA damage repair (DDR). How RAP80 itself is recruited to DNA damage sites, however, is unclear. Here, we demonstrate an intrinsic correlation between a methyltransferase DOT1L-mediated RAP80 methylation and BRCA1-A complex chromatin recruitment that occurs during cancer cell radiotherapy resistance. Mechanistically, DOT1L is quickly recruited onto chromatin and methylates RAP80 at multiple lysines in response to DNA damage. Methylated RAP80 is then indispensable for binding to ubiquitinated H2A and subsequently triggering BRCA1-A complex recruitment onto DSBs. Importantly, DOT1L-catalyzed RAP80 methylation and recruitment of BRCA1 have clinical relevance, as inhibition of DOT1L or RAP80 methylation seems to enhance the radiosensitivity of cancer cells both in vivo and in vitro. These data reveal a crucial role for DOT1L in DDR through initiating recruitment of RAP80 and BRCA1 onto chromatin and underscore a therapeutic strategy based on targeting DOT1L to overcome tumor radiotherapy resistance.
Insights
DOT1L methylates RAP80, enabling BRCA1-A complex recruitment to DNA damage sites. This process is crucial for cancer cell radiotherapy resistance and offers a therapeutic target to improve radiosensitivity.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Breast Cancer Type 1 Susceptibility Protein (BRCA1) is vital for genome stability and DNA damage repair (DDR).
- The BRCA1-A complex is recruited to double-strand breaks (DSBs) by RAP80, but RAP80's own recruitment mechanism is unknown.
- Understanding RAP80 recruitment is key to comprehending DDR and cancer radiotherapy resistance.
Purpose of the Study:
- To elucidate the mechanism of RAP80 recruitment to DNA damage sites.
- To investigate the role of DOT1L-mediated RAP80 methylation in BRCA1-A complex chromatin recruitment.
- To assess the therapeutic potential of targeting DOT1L for overcoming cancer radiotherapy resistance.
Main Methods:
- Investigated the correlation between DOT1L-mediated RAP80 methylation and BRCA1-A complex recruitment in cancer cells undergoing radiotherapy.
- Examined the recruitment of DOT1L to chromatin and its methylation of RAP80 following DNA damage.
- Assessed the binding of methylated RAP80 to ubiquitinated H2A and subsequent BRCA1-A complex recruitment.
- Evaluated the impact of DOT1L inhibition and RAP80 methylation blockade on cancer cell radiosensitivity in vitro and in vivo.
Main Results:
- Demonstrated a direct link between DOT1L-mediated RAP80 methylation and BRCA1-A complex recruitment to DSBs during radiotherapy.
- Showed that DOT1L is rapidly recruited to chromatin and methylates RAP80 at multiple lysine residues upon DNA damage.
- Confirmed that methylated RAP80 is essential for binding to ubiquitinated H2A, facilitating BRCA1-A complex assembly at DSBs.
- Found that inhibiting DOT1L or RAP80 methylation significantly enhances cancer cell radiosensitivity.
Conclusions:
- Revealed a critical role for DOT1L in DDR by initiating the recruitment of RAP80 and the BRCA1-A complex to chromatin.
- Established DOT1L-catalyzed RAP80 methylation as a key step in the DNA damage response pathway.
- Highlighted the therapeutic relevance of targeting DOT1L to enhance tumor radiosensitivity and overcome radiotherapy resistance.
More Related Videos
Related Concept Videos
Long-patch Base Excision Repair
Base Excision Repair
The first step of...
DNA Damage can Stall the Cell Cycle
Base-pairing and DNA Repair
Overview of DNA Repair
Homologous Recombination

